Recent studies revealed that a majority of tumor‐infiltrated NK cells and CD8+ T cells express the NKG2A receptor that transmits the inhibitory signal to inhibit the function of NK and CD8+ T cells upon binding with HLA‐E in human or Qa‐1b ligand in mice.9, 10. The gene discussed is HLA-E; the disease is neoplasm.